Search

Search Constraints

You searched for: Author/Creator Powell, Nick

Search Results

1. A population of naive‐like CD4+ T cells stably polarized to the TH1 lineage. Issue 4 (12th February 2022)

2. Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients. (2nd September 2021)

3. Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel. Issue 10 (8th June 2020)

4. ADTU-04 Faecal calprotectin in PSC-IBD: a novel marker of cholangitis. (8th June 2018)

6. Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study. (April 2021)

7. British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitis. (July 2020)

8. British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic. Issue 6 (17th April 2020)

9. Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab. Issue 7 (7th July 2021)

10. COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study. (November 2022)